Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,831.90
-100.10
(-1.26%)
AUD/USD
0.6480
+0.0001
(+0.01%)
ASX 200
7,569.90
-94.20
(-1.23%)
OIL
80.73
-1.20
(-1.46%)
GOLD
2,303.10
+0.20
(+0.01%)
Bitcoin AUD
88,867.16
-6,091.02
(-6.41%)
Abiomed, Inc. (ABMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
381.02
0.00
(0.00%)
At close: 05:00PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
Total revenue
1,074,096
1,031,753
847,522
Cost of revenue
200,590
188,158
161,907
Gross profit
873,506
843,595
685,615
Operating expenses
Research development
167,220
163,403
121,875
Selling general and administrative
452,177
423,486
334,183
Total operating expenses
619,397
586,889
456,058
Operating income or loss
254,109
256,706
229,557
Total other income/expenses net
-
-115,986
58,663
Income before tax
341,164
190,560
288,220
Income tax expense
74,400
54,055
62,695
Income from continuing operations
266,764
136,505
225,525
Net income
266,764
136,505
225,525
Net income available to common shareholders
266,764
136,505
225,525
Basic EPS
-
3.00
5.00
Diluted EPS
-
2.98
4.94
Basic average shares
-
45,445
45,140
Diluted average shares
-
45,881
45,674
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.